Anna Arretini

574 total citations
14 papers, 348 citations indexed

About

Anna Arretini is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Anna Arretini has authored 14 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cardiology and Cardiovascular Medicine, 1 paper in Surgery and 1 paper in Molecular Biology. Recurrent topics in Anna Arretini's work include Cardiomyopathy and Myosin Studies (12 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiovascular Effects of Exercise (4 papers). Anna Arretini is often cited by papers focused on Cardiomyopathy and Myosin Studies (12 papers), Cardiovascular Function and Risk Factors (6 papers) and Cardiovascular Effects of Exercise (4 papers). Anna Arretini collaborates with scholars based in Italy, United States and United Kingdom. Anna Arretini's co-authors include Iacopo Olivotto, Franco Cecchi, Ethan J. Rowin, Martin S. Maron, Benedetta Tomberli, Mattia Targetti, Barry J. Maron, Susan A. Casey, Raymond H. Chan and Mark S. Link and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Anna Arretini

14 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Arretini Italy 7 339 72 65 27 13 14 348
Mattia Targetti Italy 10 279 0.8× 63 0.9× 58 0.9× 31 1.1× 18 1.4× 21 308
Jakob Norsk Denmark 6 140 0.4× 45 0.6× 25 0.4× 18 0.7× 9 0.7× 14 161
Ashley Nisbet United Kingdom 9 293 0.9× 66 0.9× 52 0.8× 14 0.5× 7 0.5× 24 329
Christopher Critoph United Kingdom 9 211 0.6× 32 0.4× 67 1.0× 11 0.4× 72 5.5× 14 242
Keren Hasbani United States 4 133 0.4× 41 0.6× 42 0.6× 13 0.5× 10 0.8× 8 155
Jean B. Moubarak United States 5 339 1.0× 27 0.4× 49 0.8× 58 2.1× 16 1.2× 7 389
Takeshi Aiba Japan 9 157 0.5× 21 0.3× 37 0.6× 10 0.4× 14 1.1× 18 200
Nesan Shanmugam United Kingdom 9 328 1.0× 38 0.5× 47 0.7× 27 1.0× 7 0.5× 18 366
Paweł Derejko Poland 9 370 1.1× 24 0.3× 47 0.7× 20 0.7× 6 0.5× 61 386
L Carratino Italy 6 299 0.9× 83 1.2× 32 0.5× 17 0.6× 7 0.5× 13 314

Countries citing papers authored by Anna Arretini

Since Specialization
Citations

This map shows the geographic impact of Anna Arretini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Arretini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Arretini more than expected).

Fields of papers citing papers by Anna Arretini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Arretini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Arretini. The network helps show where Anna Arretini may publish in the future.

Co-authorship network of co-authors of Anna Arretini

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Arretini. A scholar is included among the top collaborators of Anna Arretini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Arretini. Anna Arretini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Castagno, Davide, Paolo Di Donna, Iacopo Olivotto, et al.. (2021). Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: Long‐term results and clinical outcomes. Journal of Cardiovascular Electrophysiology. 32(3). 657–666. 13 indexed citations
2.
Marchi, Alberto, Carlo Fumagalli, Niccolò Maurizi, et al.. (2019). Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy. European Journal of Preventive Cardiology. 27(17). 1821–1831. 16 indexed citations
3.
Fumagalli, Carlo, Matteo Beltrami, Niccolò Maurizi, et al.. (2019). P1243Comparison of long-term clinical course and outcome of MYBPC3 - versus MYH7 - related hypertrophic cardiomyopathy. European Heart Journal. 40(Supplement_1). 1 indexed citations
4.
Cavigli, Luna, Carlo Fumagalli, Niccolò Maurizi, et al.. (2018). Timing of invasive septal reduction therapies and outcome of patients with obstructive hypertrophic cardiomyopathy. International Journal of Cardiology. 273. 155–161. 15 indexed citations
5.
Maurizi, Niccolò, Anna Arretini, Mattia Targetti, et al.. (2018). P3167Extra long term follow up of the original tuscany cohort of patients with hypertrophic cardiomyopathy. European Heart Journal. 39(suppl_1). 1 indexed citations
6.
Maurizi, Niccolò, Carlo Fumagalli, Mattia Targetti, et al.. (2018). P889Validation of a smartphone-camera based software for the identification of electrodes location on human chest. EP Europace. 20(suppl_1). i169–i169. 2 indexed citations
7.
Fumagalli, Carlo, Mattia Targetti, Silvia Passantino, et al.. (2018). 217Comparative analysis of multiple leads smartphone electrocardiograph versus standard 12-leads electrocardiograph in patients with hypertrophic cardiomyopathy. EP Europace. 20(suppl_1). i26–i26. 2 indexed citations
8.
Maurizi, Niccolò, Silvia Passantino, Gaia Spaziani, et al.. (2018). Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events. JAMA Cardiology. 3(6). 520–520. 73 indexed citations
9.
Fumagalli, Carlo, Luna Cavigli, Alessandra Rossi, et al.. (2017). P2316Outcome of septal reduction therapies for obstructive hypertrophic cardiomyopathy in a high-flow referral centre with moderate volume procedural programmes. European Heart Journal. 38(suppl_1). 1 indexed citations
10.
Ferrantini, Cecilia, Francesca Girolami, Raffaele Coppini, et al.. (2016). Impact of Genotype on the Occurrence of Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. The American Journal of Cardiology. 117(7). 1151–1159. 25 indexed citations
11.
Maron, Martin S., Ethan J. Rowin, Iacopo Olivotto, et al.. (2016). Contemporary Natural History and Management of Nonobstructive Hypertrophic Cardiomyopathy. Journal of the American College of Cardiology. 67(12). 1399–1409. 128 indexed citations
12.
Fornaro, Alessandra, Gabriele Castelli, Alessandra Rossi, et al.. (2015). Clinical Spectrum, Therapeutic Options, and Outcome of Advanced Heart Failure in Hypertrophic Cardiomyopathy. Circulation Heart Failure. 8(6). 1014–1021. 69 indexed citations
13.
Rowin, Ethan J., Barry J. Maron, Iacopo Olivotto, et al.. (2014). Abstract 14647: Stress Echocardiography Predicts Heart Failure Progression and Alters Management Strategies in Patients with Hypertrophic Cardiomyopathy. Circulation. 130(suppl_2). 1 indexed citations
14.
Rowin, Ethan J., Barry J. Maron, Iacopo Olivotto, et al.. (2013). Abstract 14979: Progressive Heart Failure is Uncommon in Patients With Nonobstructive Hypertrophic Cardiomyopathy. Circulation. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026